![Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cfe4e028-dafa-408c-afee-6010c027f638/gr3_lrg.jpg)
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology
![PDF) Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7) PDF) Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)](https://i1.rgstatic.net/publication/295082571_Structural_Basis_of_the_Interaction_between_Tuberous_Sclerosis_Complex_1_TSC1_and_Tre2-Bub2-Cdc16_Domain_Family_Member_7_TBC1D7/links/5d480fc04585153e593d1831/largepreview.png)
PDF) Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)
![Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/03065cf8-8f64-4bf1-8df1-7f34c442e956/gr2.gif)
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology
![Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9bb80e76-6384-474c-96bc-7745f2a4ab69/gr1_lrg.jpg)
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology
![Amazon.com | Ivan Troy Black Classic Crocodile Embossed Handmade Men Italian Leather Dress Shoes/Oxford Shoes (EU 47 - US 14) | Oxfords Amazon.com | Ivan Troy Black Classic Crocodile Embossed Handmade Men Italian Leather Dress Shoes/Oxford Shoes (EU 47 - US 14) | Oxfords](https://m.media-amazon.com/images/I/81weZIJUbeL._AC_UX500_.jpg)
Amazon.com | Ivan Troy Black Classic Crocodile Embossed Handmade Men Italian Leather Dress Shoes/Oxford Shoes (EU 47 - US 14) | Oxfords
![Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cdd3550f-5b24-494c-9b71-f42969956f17/gr4_lrg.jpg)